Streetbeat News

INVO

INVO Bioscience, Inc.

https://www.invobio.com

Industry

Medical - Devices

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Open

0.86

Mkt cap

3.3M

Volume

124K

High

0.88

P/E Ratio

1.21

52-wk high

3.50

Low

0.82

Div yield

N/A

52-wk low

0.63

Several stocks experienced significant movement in pre-market trading. Notable gainers include Nanobiotix S.A. (NBTX), which surged 59.3% after entering a license agreement with Janssen Pharmaceutical, and Alpine 4 Holdings, Inc. (ALPP), which gained 29.2% after its subsidiary received a $5.25m purchase order from a U.S. Government contractor. On the other hand, Neonode Inc. (NEON) and Tivic Health Systems, Inc. (TIVC) were among the biggest losers, falling 30.4% and 23.3% respectively.

Portfolio Pulse from Lisa Levin

July 10, 2023 | 12:11 pm

Several stocks experienced significant movement in Monday's mid-day session. Notable gainers include PolyMet Mining Corp. (PLM), Fresh Vine Wine, Inc. (VINE), Advanced Health Intelligence Ltd. (AHI), SQZ Biotechnologies Company (SQZ), and IMAC Holdings, Inc. (BACK). Major losers include Atento S.A. (ATTO), Tattooed Chef, Inc. (TTCF), Protagonist Therapeutics, Inc. (PTGX), 22nd Century Group, Inc. (XXII), and VBI Vaccines Inc. (VBIV).

Portfolio Pulse from Lisa Levin

July 03, 2023 | 5:22 pm

During Friday's pre-market session, several health care stocks experienced significant movement. Renalytix, Cyteir Therapeutics, CymaBay Therapeutics, CytomX Therapeutics, Baudax Bio, and Alvotech saw their stocks rise, with Renalytix leading the gainers with a 38.6% increase. On the other hand, Unicycive Therapeutics, Surgalign Holdings, Ontrak, Kiromic BioPharma, InspireMD, and INVO Bioscience saw their stocks fall, with Unicycive Therapeutics leading the losers with a 24.2% decrease.

Portfolio Pulse from Benzinga Insights

June 30, 2023 | 1:12 pm

INVO Bioscience has received FDA clearance for the expanded use of its INVOcell device, now cleared for a 5-day incubation period. The supporting data shows improved patient outcomes, similar to IVF.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 1:02 pm

Healthcare stocks experienced significant movement during Monday's intraday session, with Benitec Biopharma, MoonLake, INVO Bioscience, Femasys, ORIC Pharmaceuticals, and Belite Bio among the gainers, while Avalo Therapeutics, FibroGen, BioVie, Pieris Pharmaceuticals, Entrada Therapeutics, and Bio-Path Hldgs were among the losers.

Portfolio Pulse from Benzinga Insights

June 26, 2023 | 5:37 pm

Carnival Corporation shares fell 9% after reporting Q2 financial results and issuing guidance. Other stocks experienced significant gains and losses during Monday's mid-day session, with Benitec Biopharma, TRxADE HEALTH, and MoonLake Immunotherapeutics among the top gainers, while Avalo Therapeutics and FibroGen saw significant declines.

Portfolio Pulse from Lisa Levin

June 26, 2023 | 4:31 pm

In Monday's pre-market session, several healthcare stocks experienced significant price movements. Gainers included MoonLake, INVO Bioscience, Femasys, Benitec Biopharma, SQZ Biotechnologies, and CollPlant Biotechnologies. Losers were Avalo Therapeutics, FibroGen, Surgalign Holdings, Nutriband, SCWorx, and Bio-Path Holdings.

Portfolio Pulse from Benzinga Insights

June 26, 2023 | 1:12 pm

Lucid Group shares are trading higher by around 8% in pre-market trading after announcing a technology partnership with Aston Martin worth over $450 million. Other pre-market gainers include TRxADE HEALTH, Digital Media Solutions, and INVO Bioscience, while losers include Lulu's Fashion Lounge Holdings, Babylon Holdings, and SCWorx Corp.

Portfolio Pulse from Lisa Levin

June 26, 2023 | 12:19 pm

Squarespace shares rose 7.2% after announcing a definitive agreement to acquire Google Domains assets. Other stocks experienced significant gains, including Oncorus, Evelo Biosciences, Navidea Biopharmaceuticals, and Virgin Galactic Holdings.

Portfolio Pulse from Lisa Levin

June 16, 2023 | 5:08 pm

On Wednesday, 33 stocks hit new 52-week lows, with UnitedHealth Group being the largest company by market cap and Biocept the smallest. Tenon Medical shares traded down 51.96%, while Camber Energy shares gained 0.16% after reaching their 52-week low.

Portfolio Pulse from Benzinga Insights

June 14, 2023 | 5:13 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.